Article Listing - Stock Commentary - New York week to Dec 10, 2007

ROFERON-A COULD SAVE SIGHT

16 March 1992

Swiss major Hoffmann-La Roche's Roferon-A (recombinant interferon alfa-2a) may prove to be a useful treatment for certain elderly patients who...

GI/AHP SMALL MOLECULE AGREE'T

16 March 1992

US biopharmaceutical company Genetics Institute and American Home Products have announced a new collaboration for the discovery and development of...

ITALY'S RECORDATI SEEKS US CR PARTNER

16 March 1992

Speaking at a Mabon Securities' meeting in New York, the Italian drugmaker Recordati made it be known that it was...

$95 MILLION CAPITAL INFUSION FOR ROBERTS

16 March 1992

Yamanouchi Pharmaceuticals of Japan last month completed a previously-approved (Marketletter January 1 and 6) purchase of about 29% of the...

IVAX TO BUY S&N'S SOLOPAK UNIT

16 March 1992

Following the recent announcement that UK-based Smith & Nephew was to sell its Solopak division, it is now known that...

FRENCH HEALTH SECTOR REFORMS

16 March 1992

Strong, domestically-owned companies with a high level of domestic investment, such as Rhone-Poulenc Rorer and Sanofi, will have less to...

UK PHARMACY STUDY URGES MORE OTCs

16 March 1992

A new report on the future of community pharmacy in the UK has called for an increase in the...

STOCK MARKET COMMENTARY: NEW YORK

16 March 1992

NEW YORK: saw the Dow Jones move down for nearly the whole of the reporting week, closing on a subdued...

ANALYST EMPLOYMENT MOVES

16 March 1992

- UK pharmaceuticals analyst Percy Lomax has joined Fleming, moving from Shep-pards. And Mark Tracey has moved from Paribas to...

APPOINTMENTS AT JANSSEN

16 March 1992

- Janssen Pharmaceutica Inc of Canada has announced the following new appointments: Peter Simpson to vice president, finance and...

Showing 94631-94640 of 95329 articles

Go to beginningPreviousNextGo to end